Stott D J, McLellan A R, Finlayson J, Chu P, Alexander W D
Department of Geriatric Medicine, Gartnavel General Hospital, Glasgow.
Q J Med. 1991 Jan;78(285):77-84.
The clinical and biochemical characteristics of 15 elderly patients with low levels of thyrotrophin (TSH) (< 0.1 mU/L) but normal free tri-iodothyronine (T3) and free thyroxine (T4) (group S) were compared with 10 euthyroid subjects (group E) and 10 hyperthyroid patients (group T). Free T3 and free T4 were significantly higher (p < 0.05) in group S (6.3 +/- 0.5 and 18.6 +/- 1.0 pmol/l, respectively) than in group E (4.6 +/- 0.3, 12.6 +/- 0.6). In common with elderly hyperthyroid patients (group T), patients in group S had few signs or symptoms of thyrotoxicosis, but the Wayne score (clinical index of hyperthyroidism) was higher in group S than in euthyroid subjects (p < 0.05). Thyroid microsomal, thyroglobulin or thyrotrophin receptor antibodies were common in group T (n = 9) but not in groups S (n = 2) or E (n = 1). This suggests a low prevalence of Graves' disease in group S compared to group T. Combined thyrotrophin releasing hormone (TRH; 200 micrograms i.v.) and gonadotrophin releasing hormone (GnRH; 100 micrograms i.v.) tests were performed; no cases of low TSH due to hypopituitarism were identified in group S. During a mean of 7.9 (4-12) months of observation TSH reverted to the normal range (> 0.2 mU/L) in 7 of 15 patients in group S; thyroid hormone concentrations rose above the normal range in four, however, only two patients required treatment for hyperthyroidism.(ABSTRACT TRUNCATED AT 250 WORDS)
将15例促甲状腺激素(TSH)水平低(<0.1 mU/L)但游离三碘甲状腺原氨酸(T3)和游离甲状腺素(T4)正常的老年患者(S组)的临床和生化特征,与10例甲状腺功能正常的受试者(E组)和10例甲状腺功能亢进患者(T组)进行比较。S组的游离T3和游离T4(分别为6.3±0.5和18.6±1.0 pmol/L)显著高于E组(4.6±0.3,12.6±0.6)(p<0.05)。与老年甲状腺功能亢进患者(T组)一样,S组患者几乎没有甲状腺毒症的体征或症状,但S组的韦恩评分(甲状腺功能亢进临床指数)高于甲状腺功能正常的受试者(p<0.05)。甲状腺微粒体、甲状腺球蛋白或促甲状腺激素受体抗体在T组常见(n=9),但在S组(n=2)和E组(n=1)中不常见。这表明S组与T组相比,格雷夫斯病的患病率较低。进行了联合促甲状腺激素释放激素(TRH;静脉注射200微克)和促性腺激素释放激素(GnRH;静脉注射100微克)试验;S组未发现因垂体功能减退导致低TSH的病例。在平均7.9(4-12)个月的观察期内,S组15例患者中有7例的TSH恢复到正常范围(>0.2 mU/L);然而,4例患者的甲状腺激素浓度升至正常范围以上,只有2例患者需要接受甲状腺功能亢进治疗。(摘要截短于250字)